HOW TO ANTICOAGULATE: CLINIC AND MANAGEMENT OF PULMONARY THROMBOEMBOLISM – LITERATURE REVIEW (Atena Editora)

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributor.authorPARRA, AYUMI FUKUYAMA-
Autor(es): dc.contributor.authorCHAVES, SAMANTTHA CRISTINA DA SILVA-
Autor(es): dc.contributor.authorLOPES, CLAUDEVIR MARIN-
Autor(es): dc.contributor.authorLUNA, AMANDA CAVALCANTE LIMA-
Autor(es): dc.contributor.authorFERNANDES, DAYANA DE LOURDES ARAUJO GARCEZ-
Autor(es): dc.contributor.authorTOMA, ANNY IZUMI-
Autor(es): dc.contributor.authorMACHADO, LAYO ABREU-
Autor(es): dc.contributor.authorVITIELLO, GABRIEL PACHA-
Autor(es): dc.contributor.authorPASSOS, HUGO SUCHURER-
Autor(es): dc.contributor.authorSATO, ÁNDREW SUGURU-
Autor(es): dc.contributor.authorSANTOS, LUCAS DANIEL DOS-
Autor(es): dc.contributor.authorATAIDE, GLÉGISON LUAN RODRIGUES-
Autor(es): dc.contributor.authorBARBOSA, GABRIELLA DE MENEZES-
Autor(es): dc.contributor.authorGADELHA, MARCELA MARIA BUARQUE DE MACEDO-
Autor(es): dc.contributor.authorALVES, ELMA OLIVEIRA-
Autor(es): dc.contributor.authorSILVA, VÂNIA GOMES DA-
Data de aceite: dc.date.accessioned2024-03-26T03:35:38Z-
Data de disponibilização: dc.date.available2024-03-26T03:35:38Z-
Data de envio: dc.date.issued2024-03-26-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/743451-
Resumo: dc.description.abstractIntroduction: Pulmonary thromboembolism is a clinical syndrome characterized by obstruction of the pulmonary artery or one of its branches by thrombi, air or fat droplets, originating from the systemic venous circulation (Konstantinides SV, et al. 2014). Goal: To review anticoagulation and management of pulmonary thromboembolism. Result: We must reach the state of full anticoagulation within the first 24 hours of therapy. This is only possible with the use of parenteral medications or new oral anticoagulants (direct thrombin or factor Xa inhibitors), whose onset of action is immediate (Tapson VF, 2008). Conclusion: Anticoagulation reduces the mortality rate by around 80-90%, basically due to its ability to prevent PTE recurrence (secondary prevention) (Kline JA, et al. 2008).pt_BR
Idioma: dc.language.isoenpt_BR
Palavras-chave: dc.subjectPulmonary embolismpt_BR
Título: dc.titleHOW TO ANTICOAGULATE: CLINIC AND MANAGEMENT OF PULMONARY THROMBOEMBOLISM – LITERATURE REVIEW (Atena Editora)pt_BR
Tipo de arquivo: dc.typelivro digitalpt_BR
Aparece nas coleções:Livros digitais